You are here: Industry Insights > Japan

News List

Japanese Pharmaceutical Market & Registration Strategies- Part 2 Deepak Hegde
November 12, 2024
The second article in the series focuses on strategies for success in registering products on the Japanese market.
Japanese Pharmaceutical Market & Registration Strategies – Part 1 Deepak Hegde
November 12, 2024
The article provides an outline of characteristics、Regulatory bodies、 Pricing、Reimbursement、the process of registering an innovative drug and generic drugs in Japan.
Quality Sourcing Opportunities at 2022 Zhejiang Export Commodity Online Fair “Japan & Republic of Korea Station – APIs session”! PharmaSources.com
May 09, 2022
The 2022 Zhejiang Export Commodity Online Fair (Pharma Sector) is coming with a new session. The portals for the “Japan & Republic of Korea Station - APIs session” is now launched to welcome the participation of both pharmaceutical suppliers located in Zh
Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19 worldpharmanews
July 26, 2021
Roche announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Ronapreve™ (casirivimab and imdevimab), for the treatment of patients with mild to moderate COVID-19 via intravenous infusion.
Japan First to Approve Roche’s Ronapreve to Treat COVID-19 contractpharma
July 22, 2021
Roche received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for Ronapreve (casirivimab and imdevimab), for the treatment of mild to moderate COVID-19 via intravenous infusion.
A Drop for Clear Vision: Japan Has Surpassed Itself Again with the Development of Ultra-High-Concentration Lutein prnasia
July 14, 2021
According to the World Report on Vision published in 2020 by World Health Organization (WHO), the incidence of most eye diseases and visual impairments varies by age, area of residence, and income level.
AstraZeneca COVID-19 Vaccine Vaxzevria Authorized for Emergency Use in Japan americanpharmaceuticalreview
May 24, 2021
AstraZeneca’s COVID-19 vaccine, Vaxzevria, has been granted special approval for emergency use in Japan for active immunization of individuals aged 18 years and older, to prevent COVID-19 caused by SARS-CoV-2.
Moderna might manufacture COVID-19 vaccines in Japan expresspharma
May 24, 2021
Moderna Inc is considering manufacturing its COVID-19 vaccine in Japan, Nikkei newspaper reported, citing an interview with Stephane Bancel, the company’s CEO.
New Pathway Launched for Pioneering Life Science Companies Seeking Japanese Market Entry prnasia
April 16, 2021
Today, pioneering life science organizations seeking to navigate Japanese market entry gained a new pathway. Shonan Health Innovation Park ("Shonan iPark", Kanagawa Prefecture, Japan) announced new membership offerings for innovation and ...
Takeda sells Japan’s non-core products portfolio to Teijin Pharma pharmaceutical-technology
April 02, 2021
Takeda Pharmaceutical has completed the asset transfer linked to a portfolio of select non-core products in Japan to Teijin Pharma for $1.25bn (JPY133bn).

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page